2-(2-Phenylmorpholin-4-yl)pyrimidin-4(3H)-ones; A new class of potent, selective and orally active glycogen synthase kinase-3β inhibitors

Kenji Fukunaga, Fumiaki Uehara, Keiichi Aritomo, Aya Shoda, Shinsuke Hiki, Masahiro Okuyama, Yoshihiro Usui, Kazutoshi Watanabe, K. Yamakoshi, Toshiyuki Kohara,

Bioorganic & Medicinal Chemistry Letters · 2013 · 32 citations · 14 references

DOIFull text

Open access

Concepts

References

14